With potential $4 billion Pfizer deal, 'upside-down' Peninsula biotech on hunt for more drugs
December 28, 2020 at 16:26 PM EST
It is the second time that Pfizer has stepped in with a deal for a prostate cancer drug shepherded through development by the Bay Area company's CEO.
